Zobair M. Younossi, MD, MPH

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.

Patients with publicly sponsored insurance who were listed for liver transplantation have worse wait-list and posttransplant outcomes, as shown using the US Scientific Registry of Transplant Recipients (2001-2017).

The Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.